Peters, Remco P.H.Maduna, Liteboho DanielKock, Marleen M.McIntyre, James A.Klausner, Jeffrey DMedina‑Marino, Andrew2022-11-092022-11-092021-02Peters, R.P.H., Maduna, L., Kock, M.M. et al. 2021, 'Single-dose azithromycin for genital lymphogranuloma venereum biovar Chlamydia trachomatis infection in HIV-infected women in South Africa: an observational study', Sexually Transmitted Diseases, vol. 48, no. 2, pp. e15-e17, doi: 10.1097/OLQ.0000000000001243.0148-5717 (print)1537-4521 (online)10.1097/OLQ.0000000000001243https://repository.up.ac.za/handle/2263/88213We conducted an observational study of lymphogranuloma venereum (LGV) biovar Chlamydia trachomatis infection in HIV-infected women in South Africa. The LGV biovar was detected in vaginal specimens of 17 (20%) of 85 women with C. trachomatis infection; 29% were symptomatic. All cases were negative for the LGV biovar after single-dose azithromycin.en© 2021 by the American Sexually Transmitted Diseases Association. This is a non-final version of an article published in final form in Sexually Transmitted Diseases, vol. 48, no. 2, pp. e15-e17, 2021, doi: 10.1097/OLQ.0000000000001243.Lymphogranuloma venereum (LGV)Chlamydia trachomatis (CT)InfectionHuman immunodeficiency virus (HIV)Women living with HIV (WLHIV)South Africa (SA)LGV biovarPostprint Article